| Completed | 2 | 30 | US | Rucaparib, Rubraca, Bevacizumab, Avastin, Atezolizumab, Tecentriq | Medical College of Wisconsin, Genentech, Inc., Clovis Oncology, Inc. | Endometrial Cancer, Uterine Carcinosarcoma | 03/23 | 04/23 | | |
NCT04624178: A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma |
|
|
| Active, not recruiting | 2 | 20 | US | Rucaparib, Nivolumab | Memorial Sloan Kettering Cancer Center, Bristol-Myers Squibb, Clovis Oncology, Inc. | Leiomyosarcoma | 11/24 | 11/24 | | |
